XML 15 R5.htm IDEA: XBRL DOCUMENT v3.22.4
Unaudited Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 3 Months Ended 6 Months Ended
Nov. 26, 2022
Nov. 27, 2021
Nov. 26, 2022
Nov. 27, 2021
Operating activities:        
Net income $ 5,549 $ 4,122 $ 11,873 $ 6,757
Adjustments to reconcile net income to cash (used in) provided by operating activities:        
Depreciation and amortization 893 859 1,776 1,688
Inventory provisions 124 57 195 140
Share-based compensation expense 213 153 524 372
(Gain) loss on disposal of assets (25) 2 (25) 2
Deferred income taxes 27 (23) 28 12
Change in assets and liabilities:        
Accounts receivable (2,009) 1,862 (5,505) (3,146)
Inventories (7,658) (4,225) (18,126) (9,182)
Prepaid expenses and other assets 774 (994) (425) (1,056)
Accounts payable (699) 1,695 796 2,302
Accrued liabilities (1,062) 1,032 1,147 1,512
Other (49) 91 589 357
Net cash (used in) provided by operating activities (3,922) 4,631 (7,153) (242)
Investing activities:        
Capital expenditures (1,301) (770) (2,743) (1,607)
Proceeds from sale of assets 193 0 193 0
Net cash used in investing activities (1,108) (770) (2,550) (1,607)
Financing activities:        
Proceeds from issuance of common stock 1,517 672 2,902 724
Cash dividends paid (831) (792) (1,650) (1,578)
Other 0 (46) (69) (91)
Net cash provided by (used in) financing activities 686 (166) 1,183 (945)
Effect of exchange rate changes on cash and cash equivalents (183) (448) (869) (857)
(Decrease) increase in cash and cash equivalents (4,527) 3,247 (9,389) (3,651)
Cash and cash equivalents at beginning of period 30,633 36,418 35,495 43,316
Cash and cash equivalents at end of period $ 26,106 $ 39,665 $ 26,106 $ 39,665